Market Overview

Benzinga's Top Upgrades, Downgrades For March 31, 2020

Share:

Upgrades

  • For Ultrapar Participacoes SA (NYSE: UGP), B of A Securities upgraded the stock from Neutral to Buy. For the fourth quarter, Ultrapar Participacoes had an EPS of \ No EPS Value , compared to year-ago quarter EPS of $0.25. The stock has a 52-week-high of $12.37 and a 52-week-low of $1.97. Ultrapar Participacoes's stock last closed at $2.43 per share.
  • For The Wendy's Co (NASDAQ: WEN), Cowen & Co. upgraded the stock from Market Perform to Outperform. For the fourth quarter, Wendy's had an EPS of $0.08, compared to year-ago quarter EPS of $0.16. The stock has a 52-week-high of $24.04 and a 52-week-low of $6.82. Wendy's's stock last closed at $14.97 per share.
  • For Corteva Inc (NYSE: CTVA), Susquehanna upgraded the stock from Neutral to Positive. Interestingly, in the fourth quarter, Corteva's EPS was $0.07. The stock has a 52-week-high of $32.78 and a 52-week-low of $20.38. Corteva's stock last closed at $24.14 per share.
  • Wedbush changed the rating for The Wendy's Co (NASDAQ: WEN) from Neutral to Outperform. In the fourth quarter, Wendy's showed an EPS of $0.08, compared to $0.16 from the year-ago quarter. The stock has a 52-week-high of $24.04 and a 52-week-low of $6.82. Wendy's's stock last closed at $14.97 per share.
  • For IDEX Corp (NYSE: IEX), Cowen & Co. upgraded the stock from Market Perform to Outperform. For the fourth quarter, IDEX had an EPS of $1.33, compared to year-ago quarter EPS of $1.31. The stock has a 52-week-high of $178.14 and a 52-week-low of $104.56. IDEX's stock last closed at $136.88 per share.
  • For Dollar General Corp (NYSE: DG), Wells Fargo upgraded the stock from Equal-Weight to Overweight. For the fourth quarter, Dollar General had an EPS of $2.10, compared to year-ago quarter EPS of $1.84. The stock has a 52-week-high of $167.44 and a 52-week-low of $116.15. Dollar General's stock last closed at $146.66 per share.
  • Exane BNP Paribas changed the rating for Oracle Corp (NYSE: ORCL) from Neutral to Outperform. Oracle earned $0.97 in the third quarter, compared to $0.87 in the year-ago quarter. The stock has a 52-week-high of $60.50 and a 52-week-low of $39.71. Oracle's stock last closed at $50.33 per share.
  • Barclays changed the rating for Grupo Aeroportuario del Centro Norte SAB de CV (NASDAQ: OMAB) from Underweight to Overweight. In the fourth quarter, Central North Airport Gr showed an EPS of $0.82, compared to $0.84 from the year-ago quarter. The stock has a 52-week-high of $67.07 and a 52-week-low of $20.55. Central North Airport Gr's stock last closed at $26.44 per share.
  • For The Mosaic Co (NYSE: MOS), B of A Securities upgraded the stock from Neutral to Buy. Mosaic earned ($0.29) in the fourth quarter, compared to $0.77 in the year-ago quarter. The stock has a 52-week-high of $28.01 and a 52-week-low of $6.50. Mosaic's stock last closed at $10.00 per share.
  • For Cirrus Logic Inc (NASDAQ: CRUS), B of A Securities upgraded the stock from Underperform to Buy. For the third quarter, Cirrus Logic had an EPS of $1.41, compared to year-ago quarter EPS of $0.91. The stock has a 52-week-high of $91.63 and a 52-week-low of $37.24. Cirrus Logic's stock last closed at $64.04 per share.
  • For Apache Corp (NYSE: APA), UBS upgraded the stock from Sell to Neutral. For the fourth quarter, Apache had an EPS of $0.08, compared to year-ago quarter EPS of $0.31. The stock has a 52-week-high of $38.12 and a 52-week-low of $3.80. Apache's stock last closed at $4.10 per share.
  • For Hewlett Packard Enterprise Co (NYSE: HPE), Wells Fargo upgraded the stock from Equal-Weight to Overweight. Hewlett Packard earned $0.44 in the first quarter, compared to $0.42 in the year-ago quarter. The stock has a 52-week-high of $17.59 and a 52-week-low of $7.43. Hewlett Packard's stock last closed at $10.04 per share.

 

Downgrades

  • For Avrobio Inc (NASDAQ: AVRO), H.C. Wainwright downgraded the stock from Buy to Neutral. Avrobio earned ($0.72) in the fourth quarter, compared to ($0.67) in the year-ago quarter. The stock has a 52-week-high of $29.32 and a 52-week-low of $9.76. Avrobio's stock last closed at $16.53 per share.
  • For Teladoc Health Inc (NYSE: TDOC), Berenberg downgraded the stock from Buy to Hold. Teladoc Health earned ($0.26) in the fourth quarter, compared to ($0.35) in the year-ago quarter. The stock has a 52-week-high of $176.40 and a 52-week-low of $48.57. Teladoc Health's stock last closed at $163.59 per share.
  • Goldman Sachs changed the rating for Amarin Corp PLC (NASDAQ: AMRN) from Buy to Neutral. For the fourth quarter, Amarin Corp had an EPS of $0.02, compared to year-ago quarter EPS of ($0.09). The stock has a 52-week-high of $26.12 and a 52-week-low of $8.58. Amarin Corp's stock last closed at $13.58 per share.
  • For Venus Concept Inc (NASDAQ: VERO), Oppenheimer downgraded the stock from Outperform to Perform. Venus Concept earned ($1.07) in the fourth quarter. The stock has a 52-week-high of $9.00 and a 52-week-low of $2.06. Venus Concept's stock last closed at $3.64 per share.
  • DA Davidson changed the rating for Great Western Bancorp Inc (NYSE: GWB) from Buy to Neutral. In the first quarter, Great Western Bancorp showed an EPS of $0.77, compared to $0.79 from the year-ago quarter. The stock has a 52-week-high of $36.65 and a 52-week-low of $16.87. Great Western Bancorp's stock last closed at $20.77 per share.
  • HC Wainwright & Co. downgraded the stock for Avrobio Inc (NASDAQ: AVRO) from Buy to Neutral. For the fourth quarter, Avrobio had an EPS of ($0.72), compared to year-ago quarter EPS of ($0.67). The stock has a 52-week-high of $29.32 and a 52-week-low of $9.76. Avrobio's stock last closed at $16.53 per share.
  • For Cronos Group Inc (NASDAQ: CRON), Canaccord Genuity downgraded the stock from Hold to Sell. In the fourth quarter, Cronos Group showed an EPS of $0.16, compared to ($0.05) from the year-ago quarter. The stock has a 52-week-high of $19.24 and a 52-week-low of $4.00. Cronos Group's stock last closed at $6.34 per share.
  • For Xylem Inc (NYSE: XYL), Atlantic Equities downgraded the stock from Overweight to Neutral. Xylem earned $0.89 in the fourth quarter, compared to $0.88 in the year-ago quarter. The stock has a 52-week-high of $89.34 and a 52-week-low of $54.62. Xylem's stock last closed at $66.30 per share.
  • KeyBanc changed the rating for Synaptics Inc (NASDAQ: SYNA) from Overweight to Sector Weight. In the second quarter, Synaptics showed an EPS of $2.04, compared to $1.55 from the year-ago quarter. The stock has a 52-week-high of $84.75 and a 52-week-low of $26.34. Synaptics's stock last closed at $59.65 per share.
  • Barclays changed the rating for Grupo Aeroportuario del Pacifico SAB de CV (NYSE: PAC) from Overweight to Equal-Weight. For the fourth quarter, Grupo Aeroportuario del had an EPS of $1.35, compared to year-ago quarter EPS of $1.28. The stock has a 52-week-high of $135.31 and a 52-week-low of $44.28. Grupo Aeroportuario del's stock last closed at $54.93 per share.

 

Initiations

  • Guggenheim Securities initiated coverage on Arena Pharmaceuticals Inc (NASDAQ: ARNA) with a Buy rating. The price target for Arena Pharmaceuticals is set at $95.00. Arena Pharmaceuticals earned ($1.76) in the fourth quarter, compared to ($0.82) in the year-ago quarter. The stock has a 52-week-high of $64.48 and a 52-week-low of $32.95. Arena Pharmaceuticals's stock last closed at $42.12 per share.
 

Related Articles (AMRN + APA)

View Comments and Join the Discussion!

Posted-In: Initiations top upgradesUpgrades Downgrades Initiation Intraday Update Analyst Ratings

Latest Ratings

StockFirmActionPT
MRVLCFRAMaintains35.0
CSIQCFRAUpgrades22.0
MGNXSVB LeerinkMaintains27.0
EVCFRAMaintains43.0
RCUSSVB LeerinkReiterates42.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com